INNOVATIVE RESEARCH & EDUCATION
The Institute for Biomedical Sciences is training future generations of leading biomedical scientists and professionals through a unique approach to education that highlights the connection among science, business and law and teaches sought-after, technical skills in our advanced labs. Our world-class researchers are tackling some of the most urgent human diseases such as COVID-19, developing new vaccines, diagnostics and therapeutics in research centers focused on microbial pathogenesis, translational immunology and inflammation, immunity and infection.
Breakthroughs in Georgia: Enterprising Biomedicine
In a very short time, Georgia State University has built an impressive research enterprise. It’s the Institute for Biomedical Sciences, and its scientists are unlocking new insights and answers to an array of diseases and ailments. Tens of millions of dollars in research grants flow into the institute each year, and the university is planning even more expansion.
Explore Our Programs
Biomedical Science Research
STOPPING A GLOBAL KILLER
FIGHTING DISEASE THREATS
While humans have encountered some deadly viruses over the centuries such as influenza, Ebola, smallpox, SARS, MERS and HIV, there are inevitably new, life-threatening diseases out there waiting to emerge. Experts have agreed that it wasn’t a question of if – but when – another lethal infectious agent would occur and speculated if the world would be ready to fight it. Sadly, the answer is no.
News Stories & Events
More
Top Stories
Compounds That Inhibit SARS-CoV-2 Replication Identified by Biomedical Sciences Researchers
Compounds targeting enzymes that control key processes such as fatty acid metabolism and functions related to cell membranes that are required to efficiently produce infectious viruses are potent inhibitors of SARS-CoV-2, the virus that causes COVID-19, according to a study led by the Institute for Biomedical Sciences at Georgia State. read more ❯
Biomedical Sciences Researcher Gets $2.7 Million Federal Grant To Study Seasonal and Universal Vaccination in Aged Populations
Dr. Sang-Moo Kang, professor in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.7 million federal grant to study seasonal and universal vaccination in elderly populations with pre-existing immunity to influenza viruses.read more ❯
Bridging The Gap
Khayla McClinton, a master’s student in the Institute for Biomedical Sciences, wants to close the health access gap and bring the voice of underrepresented communities to conversations about research, discoveries and prevention.read more ❯